PUBLISHED DATE : Jan 2023 | Pages : 306
Fill out your details & get your free sample
The Global Vitamin D Market Size, Share, And Growth Forecast By:
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
306 Pages
153 Tables
132 Charts
5 Regions
26 Countries
19 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 2.68 Billion |
| Market Size (2021) | USD 1.64 Billion |
| CAGR (2021-2027) | 8.49% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Analog, Form, Application, End User, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | BASF SE, Fermenta Biotech Limited, DSM, Dishman Carbogen Amcis, Zhejiang Garden Biochemical High-Tech Co Ltd |
The global vitamin D market was valued at USD 1.64 billion in 2021 and is expected to reach USD 2.68 billion by 2027, growing at a CAGR of 8.49% from 2021-2027. The industry is expected to generate incremental revenue of over USD 1 billion during the forecast period due to its application in the nutricosmetics, premixes, functional beverages, and vegan industries. The vitamin D market is highly competitive, with many significant vendors. Clinically proven formulas and scientific research are the major differentiating factors in the market. Over one-third of the global population is considered to have suboptimal levels of micronutrients such as vitamins and minerals. It is estimated that over 1 billion people across the globe suffer from low vitamin D levels primarily due to poor diet and lack of exposure to sunlight. Geographical, cultural, and demographic factors also play a crucial role in determining vitamin D levels.
The vitamin D market is highly characterized by the increasing demand for supplements and functional foods. The COVID-19 outbreak has further accelerated the growth of the vitamin D market. Increasing nutrition requirements, government initiatives, and lucrative investments in the end-user industries are additionally expected to drive market growth.
Emerging Therapeutic Application of Vitamin D
Numerous studies have shown that vitamin D affects many biological processes that control calcium and phosphorus metabolism, cell division, differentiation, apoptosis, immunological control, genome integrity, and neurogenesis. Additionally, recent research has revealed a strong correlation between vitamin D and various illnesses, including cancer, autoimmune, viral, and cardiovascular diseases. There is increasing evidence to support the role of the VD system in cancer prevention and treatment. Many scientific articles report on the role of the VD system in the development, progression, prognosis, and treatment of cancer. Randomized clinical trial data suggest a more significant benefit of vitamin D over cancer mortality and survival than cancer incidence. These data indicate that vitamin D may play a role in reducing advanced or fatal cancers. According to laboratory and animal research, vitamin D may decrease tumors' development and prevent cancer cell growth.
Increasing Demand for Vitamin D Formulation in Personal Care
Dermatologists praise the benefits of the ingredient in topical skincare, and the outcomes are striking. Vitamin D has several anti-oxidative, proliferative, anti-inflammatory, and healing properties. Applying 5,000 IU of vitamin D3 cream is believed to have a therapeutic effect on people with psoriasis. Oil-based vitamin D3 solutions are highly recommended to treat psoriasis. Vitamin D beauty products are also sold OTC and therefore are readily available. Vitamin D3 protects the skin, prevents aging, and normalizes cell turnover. Vendors are also tapping vitamin D3’s potential to encourage beauty and health, which additionally contributes to the vitamin D market growth. It exerts a rejuvenating and protective effect on aging skin. For instance, through products such as VitaD Fortified Topical Elixir and Skin Authority, topical skin care formulations promote the vitamin D market.
Rising Prevalence of Vitamin D Deficiency Coupled with Consequences of Diseases
One of the most widespread medical conditions worldwide is vitamin D insufficiency. Poor bone growth and health are side effects of vitamin D insufficiency, as is an increased risk of many common and serious illnesses like type 1 diabetes, several types of cancer, and other autoimmune and cardiovascular problems. In the US, Canada, Australia, Europe, New Zealand, and Asia, it has been estimated that between 30 and 50 percent of children and adults suffer from vitamin D deficiency.
While over 1 billion people around the globe are estimated to be vitamin D deficient, over 50% of the population are estimated to have insufficient levels of vitamin D. Several epidemiological research suggest that about 24% of people in the US are vitamin D inadequate. Other regions of the globe may have higher rates of deficiency. About 40% of the population in Europe likely has vitamin D deficiency. In severe cases, vitamin D might increase the risk of osteoporosis, hip fracture, and even rickets. Rickets is more common among children and causes softening of bones, skeletal fractures, and deformity. Depression, bone pain, and weakness are other associated conditions with the disease. Such factors propel the awareness of Vitamin D, thus boosting the Vitamin D Market share globally.
INSIGHTS BY APPLICATION
In 2021, the pharmaceuticals segment accounted for 48.07% of the global vitamin D market. The pharmaceuticals segment is estimated to be higher because, in 2021, the pharmaceutical industry dominated the global vitamin D market with increasing applications in new segments such as vitamin therapy and beauty supplements. Since vitamin D is a hormone that promotes calcium absorption in the body, it is crucial for most pharmaceutical companies. With an increasing number of deficiencies and medical complications in children and adults, the role of vitamin D in the pharma industry is inevitable. Vitamin D is also considered a growth hormone. They are crucial for bone growth and mineralization in children. Pregnant women continue to drive the need for vitamin D consumption through supplements. Vitamin D deficiency can also cause hypovitaminosis D.
INSIGHTS BY FORM
There are two major forms of vitamin D, namely, dry and liquid. The dry segment reported a major share of around 71.99% in the global vitamin D market. It is estimated to be higher due to its higher stability and extended shelf life. The segment also includes beadlets and crystalline forms used in end-user industries such as pharma, animal feed, and cosmetics. Vitamin D in dry form is highly preferred for cattle feed. For instance, pregnant heifers require up to 1,887 IU/kg of vitamin D daily. Dry forms are also used in supplements owing to their higher potency and effectiveness. The surge in demand for encapsulated forms and premix formulas can enhance the growth of the dry vitamin D market segment during the forecast period. The expansions in the animal feed industry can potentially upscale the market value in countries such as China, the US, and India. Dry forms of vitamin D3 are also common in Sweden, Germany, France, the UK, Spain, and Russia European markets.
INSIGHTS BY ANALOG
Among all analogs, the vitamin D3 segment reported a significant share of around 69.58% in the global vitamin D market. The vitamin D3 segment is estimated to be higher because vitamin D3 is the biologically active form of vitamin D found in the bodies of humans and animals. Vitamin D3 is used in supplements, animal feed, and cosmetics owing to its unique advantages compared to its counterparts in terms of shelf life, activity, and bio-activeness. The demand for vitamin D3 surged following the outbreak of the COVID-19 pandemic. New formulations with vitamin D3 as the vital ingredient are expected to be manufactured during the next five years.
INSIGHTS BY END USER
The human segment under the end-user category accounts for the highest share of around 66.98% in the global vitamin D market. The Vitamin D3 segment is estimated to be higher because Vitamin D supplementation is the most appropriate treatment option for the adult population. Without adequate sun exposure, it is almost impossible to achieve adequate vitamin D levels from dietary sources, and dietary supplements are being used by many specialists as a safe and inexpensive alternative to treat vitamin D deficiency. The Institute of Medicine (IOM) recently issued new dietary guidelines for vitamin D supplementation. According to the report, children over the age of 1 and adults up to 70 are advised to take 600 IU of vitamin D daily, and adults over 70 take 800 IU of vitamin D daily. Several factors may contribute to vitamin D deficiency in the elderly because they spend most of their time indoors, and older people minimize their exposure to natural sunlight. Also, as the skin thins with age, the efficiency of vitamin D synthesis decreases significantly. Decreased appetite and malabsorption of nutrients exacerbate this problem for older people. Vitamin D deficiency during pregnancy is a global problem. Studies show that the prevalence in pregnant women ranges from 18 to 84%. Sufficient calcium and vitamin D intake during pregnancy are required for calcium homeostasis, fetal growth, and bone mineralization.
Europe accounts for a significant share of around 28.03% of the global Vitamin D Market. This is attributable to the increased usage of nutricosmetics, changing lifestyles, and the rigorous presence of pharmaceutical companies in the region is expected to maintain the growth in the coming years. In 2021, Germany, France, the UK, Spain, and Italy were the major revenue-generating countries in the European region. The region is also home to many industries like pharma, functional food & beverages, animal feed, and personal care, which procure vitamin D for manufacturing drugs, animal feed supplements, dietary supplements, and personal care products. The Netherlands, Switzerland, Denmark, and Belgium are other significant vitamin D markets for growth in the animal feed, cosmetics, and supplement segments. The region is witness to a deficiency of vitamin D in the general population. Europe is one of the best markets for the penetration of vitamin D because more than 70% of the population there is either vitamin D deficient or insufficient.
The growing number of vegans and vegetarians in the region fuels the demand for vegan-enriched foods and dietary supplements. D3 is more stable and durable, making it suitable for dietary supplements. This could pose challenges for pharmaceutical companies in the region, impacting demand for vitamin D products. Also, the COVID-19 pandemic has increased sales of vitamin D supplements in Spain.
The vitamin D market is characterized by many renowned and regional chemical companies like DSM, BASF, Fermenta Biotech, Dishman Carbogen, and Zhejiang Garden Biochemical High-Tech. For leading players such as BASF, vitamin D3 is one of their premium ingredients. It is the most temperature-stable form of the brand as the ingredient can withstand a temperature of 77° Fahrenheit with longer shelf life. The product form can be used in dietary supplements, functional food and beverages, medicinal food, and food fortification. The vitamin D market is also expected to witness the rise of new vendors specializing in the vitamin supplements segment and could be potential targets for vitamin D manufacturers. Constant online engagement is necessary to gain leads, as e-commerce plays a significant role in the wholesale market. Moreover, it also enhances the end-user experience.
Frequently Asked Questions
How big is the vitamin D market?
The global vitamin D market size was valued at USD 1.64 billion in 2021 and is expected to reach USD 2.68 billion by 2027.
What is the growth rate of the global vitamin D market?
The global vitamin D market is growing at a CAGR of 8.49% from 2022-2027.
What are the growing trends in the global vitamin D market?
The emerging therapeutic applications of vitamin D, increasing demand for vitamin D formulation in personal care, increasing trend of vegan vitamin D formulations, and emerging drug delivery technologies for administering vitamin D are growing trends in the global market.
How big is the North American vitamin D market?
The vitamin D market in North America was valued at USD 431.15 million in 2021 and is expected to reach USD 695.80 million by 2027.
Who are the prominent players influencing vitamin D market growth?
BASF SE, Fermenta Biotech Limited, DSM, Dishman Carbogen Amcis, and Zhejiang Garden Biochemical High-Tech Co Ltd are the key players in the vitamin D market.
Which region has the most extensive vitamin D market share globally?
Europe accounted for the largest share, 28.03%, in the global vitamin D market. The European region is expected to pose an absolute growth of 58.08% during the forecast period.
The vitamin D market is expected to grow at a CAGR of approximately 8.49% from 2021 to 2027.
The following factors are likely to contribute to the growth of the vitamin D market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the vitamin D market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Application
Segmentation by Form
Segmentation by Analog
Segmentation by End User
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 PREMIUM INSIGHTS
7.1 GLOBAL VITAMIN D MARKET SCENARIO
7.1.1 INSIGHTS BY MARKET DYNAMICS
7.1.2 INSIGHTS BY MARKET SEGMENTATION
7.1.3 VENDOR LANDSCAPE
8 INTRODUCTION
8.1 OVERVIEW
8.1.1 VITAMIN D IN CANCER PREVENTION AND TREATMENT
9 MARKET OPPORTUNITIES & TRENDS
9.1 EMERGING THERAPEUTIC APPLICATIONS OF VITAMIN D
9.2 INCREASING DEMAND FOR VITAMIN D FORMULATION IN PERSONAL CARE
9.3 GROWING TREND OF VEGAN VITAMIN D FORMULATIONS
9.4 EMERGING DRUG DELIVERY TECHNOLOGIES FOR ADMINISTERING VITAMIN D
10 MARKET GROWTH ENABLERS
10.1 RISING PREVALENCE OF VITAMIN D DEFICIENCY
10.2 INCREASING PUBLIC-PRIVATE COLLABORATIONS & DEMAND FOR VITAMIN D IN FOOD FORTIFICATION
10.3 RISING DEMAND FOR VITAMIN SUPPLEMENTS
10.4 APPLICATIONS IN FEED INDUSTRY
11 MARKET GROWTH RESTRAINTS
11.1 INCLINATION TOWARD NATURAL AVAILABILITY OF VITAMIN D
11.2 CONSEQUENCES OF VITAMIN D TOXICITY
11.3 ANIMAL NUTRITION INDUSTRY-ASSOCIATED RISKS
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHTS BY APPLICATION
12.2.2 INSIGHTS BY FORM
12.2.3 INSIGHTS BY ANALOG
12.2.4 INSIGHTS BY END-USER
12.2.5 INSIGHTS BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 APPLICATIONS
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PHARMACEUTICALS
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET SIZE & FORECAST
13.3.4 MARKET BY GEOGRAPHY
13.4 ANIMAL HEALTH
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 FUNCTIONAL FOOD & BEVERAGES
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
13.6 PERSONAL CARE
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 MARKET BY GEOGRAPHY
14 FORM
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 DRY
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 LIQUID
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 ANALOG
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 VITAMIN D3
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 VITAMIN D2
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 END-USER
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 HUMANS
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 ANIMALS
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 GEOGRAPHIC OVERVIEW
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 EUROPE: APPLICATION SEGMENTATION
18.2.2 EUROPE: FORM SEGMENTATION
18.2.3 EUROPE: ANALOG SEGMENTATION
18.2.4 EUROPE: END-USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 GERMANY: MARKET SIZE & FORECAST
18.3.2 SPAIN: MARKET SIZE & FORECAST
18.3.3 FRANCE: MARKET SIZE & FORECAST
18.3.4 ITALY: MARKET SIZE & FORECAST
18.3.5 UK: MARKET SIZE & FORECAST
18.3.6 RUSSIA: MARKET SIZE & FORECAST
18.3.7 POLAND: MARKET SIZE & FORECAST
19 NORTH AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 NORTH AMERICA: APPLICATION SEGMENTATION
19.2.2 NORTH AMERICA: FORM SEGMENTATION
19.2.3 NORTH AMERICA: ANALOG SEGMENTATION
19.2.4 NORTH AMERICA: END-USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 US: MARKET SIZE & FORECAST
19.3.2 CANADA: MARKET SIZE & FORECAST
20 APAC
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 APAC: APPLICATION SEGMENTATION
20.2.2 APAC: FORM SEGMENTATION
20.2.3 APAC: ANALOG SEGMENTATION
20.2.4 APAC: END-USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 CHINA: MARKET SIZE & FORECAST
20.3.2 INDIA: MARKET SIZE & FORECAST
20.3.3 JAPAN: MARKET SIZE & FORECAST
20.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
20.3.5 AUSTRALIA: MARKET SIZE & FORECAST
20.3.6 INDONESIA: MARKET SIZE & FORECAST
20.3.7 VIETNAM: MARKET SIZE & FORECAST
20.3.8 THAILAND: MARKET SIZE & FORECAST
20.3.9 MALAYSIA: MARKET SIZE & FORECAST
21 LATIN AMERICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 LATIN AMERICA: APPLICATION SEGMENTATION
21.2.2 LATIN AMERICA: FORM SEGMENTATION
21.2.3 LATIN AMERICA: ANALOG SEGMENTATION
21.2.4 LATIN AMERICA: END-USER SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 BRAZIL: MARKET SIZE & FORECAST
21.3.2 MEXICO: MARKET SIZE & FORECAST
21.3.3 ARGENTINA: MARKET SIZE & FORECAST
21.3.4 COLOMBIA: MARKET SIZE & FORECAST
22 MIDDLE EAST & AFRICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
22.2.2 MIDDLE EAST & AFRICA: FORM SEGMENTATION
22.2.3 MIDDLE EAST & AFRICA: ANALOG SEGMENTATION
22.2.4 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
22.3 KEY COUNTRIES
22.3.1 SOUTH AFRICA: MARKET SIZE & FORECAST
22.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
22.3.3 UAE: MARKET SIZE & FORECAST
22.3.4 TURKEY: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
23.1 COMPETITION OVERVIEW
23.2 MARKET SHARE ANALYSIS
24 KEY COMPANY PROFILES
24.1 BASF SE
24.1.1 BUSINESS OVERVIEW
24.1.2 BASF IN VITAMIN D MARKET
24.1.3 PRODUCT OFFERINGS
24.1.4 KEY STRATEGIES
24.1.5 KEY STRENGTHS
24.1.6 KEY OPPORTUNITIES
24.2 FARMENTA BIOTECH LIMITED
24.2.1 BUSINESS OVERVIEW
24.2.2 BASF IN VITAMIN D MARKET
24.2.3 PRODUCT OFFERINGS
24.2.4 KEY STRATEGIES
24.2.5 KEY STRENGTHS
24.2.6 KEY OPPORTUNITIES
24.3 DSM
24.3.1 BUSINESS OVERVIEW
24.3.2 DSM IN VITAMIN D MARKET
24.3.3 PRODUCT OFFERINGS
24.3.4 KEY STRATEGIES
24.3.5 KEY STRENGTHS
24.3.6 KEY OPPORTUNITIES
24.4 DISHMAN CARBOGEN AMCIS
24.4.1 BUSINESS OVERVIEW
24.4.2 DISHMAN CARBOGEN AMCIS IN VITAMIN D MARKET
24.4.3 PRODUCT OFFERINGS
24.4.4 KEY STRATEGIES
24.4.5 KEY STRENGTHS
24.4.6 KEY OPPORTUNITIES
24.5 ZHEJIANG GARDEN BIOCHEMICAL HIGH-TECH
24.5.1 BUSINESS OVERVIEW
24.5.2 ZHEJIANG GARDEN BIOCHEMICAL HIGH-TECH IN VITAMIN D MARKET
24.5.3 PRODUCT OFFERINGS
24.5.4 KEY STRATEGIES
24.5.5 KEY STRENGTHS
24.5.6 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
25.1 ADISSEO
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.2 SYNTHESIA
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.3 VITABLEND
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.4 NEWGEN PHARMA
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.5 SICHUAN NEIJIANG HUIXIN PHARMACY
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.6 HANGZHOU THINK CHEMICAL
25.6.1 BUSINESS OVERVIEW
25.6.2 PRODUCT OFFERINGS
25.7 LYCORED
25.7.1 BUSINESS OVERVIEW
25.7.2 PRODUCT OFFERINGS
25.8 PHARMAVIT
25.8.1 BUSINESS OVERVIEW
25.8.2 PRODUCT OFFERINGS
25.9 DIVI’S NUTRACEUTICALS
25.9.1 BUSINESS OVERVIEW
25.9.2 PRODUCT OFFERINGS
25.10 TOCRIS BIOSCIENCE
25.10.1 BUSINESS OVERVIEW
25.10.2 PRODUCT OFFERINGS
25.11 SPECTRUM CHEMICAL
25.11.1 BUSINESS OVERVIEW
25.11.2 PRODUCT OFFERINGS
25.12 STABICOAT VITAMINS
25.12.1 BUSINESS OVERVIEW
25.12.2 PRODUCT OFFERINGS
25.13 XIAMEN KINGDOMWAY GROUP
25.13.1 BUSINESS OVERVIEW
25.13.2 PRODUCT OFFERINGS
25.14 ZHEJIANG NHU
25.14.1 BUSINESS OVERVIEW
25.14.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
26.1 KEY TAKEAWAYS
26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
27.1 MARKET BY APPLICATION SEGMENTATION
27.1.1 EUROPE: APPLICATION SEGMENTATION
27.1.2 NORTH AMERICA: APPLICATION SEGMENTATION
27.1.3 APAC: APPLICATION SEGMENTATION
27.1.4 LATIN AMERICA: APPLICATION SEGMENTATION
27.1.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION
27.2 MARKET BY FORM SEGMENTATION
27.2.1 EUROPE: FORM SEGMENTATION
27.2.2 NORTH AMERICA: FORM SEGMENTATION
27.2.3 APAC: FORM SEGMENTATION
27.2.4 LATIN AMERICA: FORM SEGMENTATION
27.2.5 MIDDLE EAST & AFRICA: FORM SEGMENTATION
27.3 MARKET BY ANALOG SEGMENTATION
27.3.1 EUROPE: ANALOG SEGMENTATION
27.3.2 NORTH AMERICA: ANALOG SEGMENTATION
27.3.3 APAC: ANALOG SEGMENTATION
27.3.4 LATIN AMERICA: ANALOG SEGMENTATION
27.3.5 MIDDLE EAST & AFRICA: ANALOG SEGMENTATION
27.4 MARKET BY END-USER SEGMENTATION
27.4.1 EUROPE: END-USER SEGMENTATION
27.4.2 NORTH AMERICA: END-USER SEGMENTATION
27.4.3 APAC: END-USER SEGMENTATION
27.4.4 LATIN AMERICA: END-USER SEGMENTATION
27.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
27.5 MARKET BY GEOGRAPHY
27.5.1 PHARMACEUTICALS: GEOGRAPHY SEGMENTATION
27.5.2 ANIMAL HEALTH: GEOGRAPHY SEGMENTATION
27.5.3 FUNCTIONAL FOOD & BEVERAGES: GEOGRAPHY SEGMENTATION
27.5.4 PERSONAL CARE: GEOGRAPHY SEGMENTATION
27.5.5 VITAMIN D3: GEOGRAPHY SEGMENTATION
27.5.6 VITAMIN D2: GEOGRAPHY SEGMENTATION
27.5.7 DRY: GEOGRAPHY SEGMENTATION
27.5.8 LIQUID: GEOGRAPHY SEGMENTATION
27.5.9 HUMANS: GEOGRAPHY SEGMENTATION
27.5.10 ANIMALS: GEOGRAPHY SEGMENTATION
28 APPENDIX
28.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF GLOBAL VITAMIN D MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 GLOBAL VITAMIN D MARKET 2021 & 2027 ($ MILLION)
EXHIBIT 4 GLOBAL VITAMIN D MARKET SEGMENTATION
EXHIBIT 5 LIFECYCLE PLACEMENT OF GLOBAL VITAMIN D MARKET 2021
EXHIBIT 6 IMPACT OF EMERGING THERAPEUTIC APPLICATIONS OF VITAMIN D
EXHIBIT 7 VITAMIN D & SPECIFIC HEALTH CONDITIONS AND DISEASES
EXHIBIT 8 VITAMIN D EFFECTS ON CANCER
EXHIBIT 9 IMPACT OF INCREASING DEMAND FOR VITAMIN D FORMULATION IN PERSONAL CARE
EXHIBIT 10 IMPACT OF GROWING TREND OF VEGAN VITAMIN D FORMULATIONS
EXHIBIT 11 IMPACT OF EMERGING DRUG DELIVERY TECHNOLOGIES FOR ADMINISTERING VITAMIN D
EXHIBIT 12 IMPACT OF RISING PREVALENCE OF VITAMIN D DEFICIENCY
EXHIBIT 13 VULNERABLE POPULATION TO HIGH DEFICIENCY OF VITAMIN D
EXHIBIT 14 IMPACT OF INCREASING PUBLIC-PRIVATE COLLABORATIONS & DEMAND FOR VITAMIN D IN FOOD FORTIFICATION
EXHIBIT 15 IMPACT OF RISING DEMAND FOR VITAMIN SUPPLEMENTS
EXHIBIT 16 VITAMIN D SUPPLEMENTS: BENEFITS OVER FORTIFIED FOODS
EXHIBIT 17 IMPACT OF APPLICATIONS IN FEED INDUSTRY
EXHIBIT 18 IMPACT OF INCLINATION TOWARD NATURAL AVAILABILITY OF VITAMIN D
EXHIBIT 19 NATURAL SOURCES OF VITAMIN D
EXHIBIT 20 IMPACT OF CONSEQUENCES OF VITAMIN D TOXICITY
EXHIBIT 21 RISKS ASSOCIATED WITH VITAMIN D IN ELDERLY & CHILDREN
EXHIBIT 22 IMPACT OF ANIMAL NUTRITION INDUSTRY-ASSOCIATED RISKS
EXHIBIT 23 GLOBAL VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 24 GLOBAL VITAMIN D MARKET BY APPLICATION: MARKET SHARE 2021 & 2027
EXHIBIT 25 GLOBAL VITAMIN D MARKET BY FORM: MARKET SHARE 2021 & 2027
EXHIBIT 26 GLOBAL VITAMIN D MARKET BY ANALOG: MARKET SHARE 2021 & 2027
EXHIBIT 27 GLOBAL VITAMIN D MARKET BY END-USER: MARKET SHARE 2021 & 2027
EXHIBIT 28 GLOBAL VITAMIN D MARKET BY GEOGRAPHY: MARKET SHARE 2021 & 2027
EXHIBIT 29 FIVE FORCES ANALYSIS 2021
EXHIBIT 30 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 31 GLOBAL VITAMIN D MARKET BY APPLICATION
EXHIBIT 32 GLOBAL VITAMIN D MARKET BY APPLICATION: INCREMENTAL GROWTH
EXHIBIT 33 GLOBAL VITAMIN D MARKET BY APPLICATION: ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL VITAMIN D MARKET BY PHARMACEUTICALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 35 GLOBAL VITAMIN D MARKET BY PHARMACEUTICALS 2021–2027 ($ MILLION)
EXHIBIT 36 GLOBAL ANIMAL HEALTH VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 37 GLOBAL ANIMAL HEALTH VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 38 GLOBAL VITAMIN D MARKET BY FUNCTIONAL FOOD & BEVERAGES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 39 GLOBAL FUNCTIONAL FOOD & BEVERAGES VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 40 GLOBAL PERSONAL CARE VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 GLOBAL PERSONAL CARE VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 42 INCREMENTAL GROWTH BY FORM 2021 & 2027
EXHIBIT 43 GLOBAL VITAMIN D DEFICIENCY MARKET BY FORM
EXHIBIT 44 GLOBAL VITAMIN D MARKET BY FORM: INCREMENTAL GROWTH
EXHIBIT 45 GLOBAL VITAMIN D MARKET BY FORM: ABSOLUTE GROWTH
EXHIBIT 46 GLOBAL DRY VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL DRY VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 48 GLOBAL LIQUID VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL LIQUID VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY ANALOG 2021 & 2027
EXHIBIT 51 GLOBAL VITAMIN D MARKET BY ANALOG
EXHIBIT 52 GLOBAL ANALOG VITAMIN D MARKET: INCREMENTAL GROWTH
EXHIBIT 53 GLOBAL VITAMIN D MARKET BY ANALOG: ABSOLUTE GROWTH
EXHIBIT 54 GLOBAL VITAMIN D MARKET BY VITAMIN D3: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL VITAMIN D MARKET BY VITAMIN D3 2021–2027 ($ MILLION)
EXHIBIT 56 GLOBAL VITAMIN D MARKET BY VITAMIN D2: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 57 GLOBAL VITAMIN D MARKET BY VITAMIN D2 2021–2027 ($ MILLION)
EXHIBIT 58 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 59 GLOBAL VITAMIN D MARKET BY END-USER
EXHIBIT 60 GLOBAL VITAMIN D MARKET BY END-USER: INCREMENTAL GROWTH
EXHIBIT 61 GLOBAL VITAMIN D MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 62 SYMPTOMS OF VITAMIN D DEFICIENCY IN ELDERLY POPULATION
EXHIBIT 63 GLOBAL HUMAN VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 64 VITAMIN D DEFICIENCY IN CHILDREN
EXHIBIT 65 GLOBAL HUMAN VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 66 GLOBAL VITAMIN D MARKET BY ANIMALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL ANIMAL VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 68 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 69 GLOBAL VITAMIN D MARKET BY GEOGRAPHY
EXHIBIT 70 GLOBAL VITAMIN D MARKET: KEY COUNTRIES
EXHIBIT 71 GLOBAL VITAMIN D MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 72 GLOBAL VITAMIN D MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 73 EUROPE VITAMIN D MARKET: KEY COUNTRIES
EXHIBIT 74 GLOBAL VITAMIN D MARKET BY EUROPE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 EUROPE VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 76 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 77 VITAMIN D MARKET IN GERMANY 2021–2027 ($ MILLION)
EXHIBIT 78 VITAMIN D MARKET IN SPAIN 2021–2027 ($ MILLION)
EXHIBIT 79 VITAMIN D MARKET IN FRANCE 2021–2027 ($ MILLION)
EXHIBIT 80 VITAMIN D MARKET IN ITALY 2021–2027 ($ MILLION)
EXHIBIT 81 VITAMIN D DEFICIENCY & RECOMMENDED DOSE STATISTICS
EXHIBIT 82 VITAMIN D MARKET IN UK 2021–2027 ($ MILLION)
EXHIBIT 83 VITAMIN D MARKET IN RUSSIA 2021–2027 ($ MILLION)
EXHIBIT 84 VITAMIN D MARKET IN POLAND 2021–2027 ($ MILLION)
EXHIBIT 85 NORTH AMERICA VITAMIN D MARKET: KEY COUNTRIES
EXHIBIT 86 GLOBAL NORTH AMERICA VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 87 NORTH AMERICA VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 88 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 89 VITAMIN D MARKET IN US 2021–2027 ($ MILLION)
EXHIBIT 90 VITAMIN D MARKET IN CANADA 2021–2027 ($ MILLION)
EXHIBIT 91 APAC VITAMIN D MARKET: KEY COUNTRIES
EXHIBIT 92 GLOBAL APAC VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 93 APAC VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 94 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 95 DEMAND FOR DIETARY SUPPLEMENTS IN CHINA
EXHIBIT 96 VITAMIN D MARKET IN CHINA 2021–2027 ($ MILLION)
EXHIBIT 97 VITAMIN D MARKET IN INDIA 2021–2027 ($ MILLION)
EXHIBIT 98 VITAMIN D MARKET IN JAPAN 2021–2027 ($ MILLION)
EXHIBIT 99 VITAMIN D MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)
EXHIBIT 100 VITAMIN D MARKET IN AUSTRALIA 2021–2027 ($ MILLION)
EXHIBIT 101 VITAMIN D MARKET IN INDONESIA 2021–2027 ($ MILLION)
EXHIBIT 102 VITAMIN D MARKET IN VIETNAM 2021–2027 ($ MILLION)
EXHIBIT 103 VITAMIN D MARKET IN THAILAND 2021–2027 ($ MILLION)
EXHIBIT 104 VITAMIN D MARKET IN MALAYSIA 2021–2027 ($ MILLION)
EXHIBIT 105 LATIN AMERICA VITAMIN D VITAMIN MARKET: KEY COUNTRIES
EXHIBIT 106 LATIN AMERICA VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 107 VITAMIN D MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)
EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 109 VITAMIN D MARKET IN BRAZIL 2021–2027 ($ MILLION)
EXHIBIT 110 VITAMIN D MARKET IN MEXICO 2021–2027 ($ MILLION)
EXHIBIT 111 VITAMIN D MARKET IN ARGENTINA 2021–2027 ($ MILLION)
EXHIBIT 112 VITAMIN D MARKET IN COLOMBIA 2021–2027 ($ MILLION)
EXHIBIT 113 MIDDLE EAST & AFRICA: KEY COUNTRIES
EXHIBIT 114 MIDDLE EAST & AFRICA VITAMIN D MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 115 MIDDLE EAST & AFRICA VITAMIN D MARKET 2021–2027 ($ MILLION)
EXHIBIT 116 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 117 VITAMIN D MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)
EXHIBIT 118 VITAMIN D MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)
EXHIBIT 119 VITAMIN D MARKET IN UAE 2021–2027 ($ MILLION)
EXHIBIT 120 VITAMIN D MARKET IN TURKEY 2021–2027 ($ MILLION)
EXHIBIT 121 GROWTH PANORAMA OF VITAMIN D MARKET FROM INTERNAL & EXTERNAL SOURCES 2021
EXHIBIT 122 GLOBAL VITAMIN D MARKET: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 123 GLOBAL VITAMIN D MARKET: DOMINANCE ANALYSIS
EXHIBIT 124 BASF: TOTAL ANNUAL REVENUE 2020–2022 ($ MILLION)
EXHIBIT 125 BASF: REVENUE SHARE BY SEGMENT 2022 (%)
EXHIBIT 126 BASF: REVENUE SHARE BY GEOGRAPHY 2022 (%)
EXHIBIT 127 FERMENTA BIOTECH: TOTAL ANNUAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 128 FERMENTA BIOTECH: REVENUE SHARE BY SEGMENT 2022 (%)
EXHIBIT 129 DSM: TOTAL ANNUAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 130 DSM: REVENUE SHARE BY SEGMENT 2021 (%)
EXHIBIT 131 DISHMAN CARBOGEN AMCIS: TOTAL ANNUAL REVENUE 2020–2022 ($ MILLION)
EXHIBIT 132 DISHMAN CARBOGEN AMCIS: REVENUE SHARE BY SEGMENT 2022 (%)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015−2021
TABLE 3 GLOBAL PHARMACEUTICAL VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 4 GLOBAL PHARMACEUTICAL VITAMIN D MARKET 2021–2027 (%)
TABLE 5 GLOBAL ANIMAL HEALTH VITAMIN D MARKET 2021-2027 ($ MILLION)
TABLE 6 GLOBAL ANIMAL HEALTH VITAMIN D MARKET 2021−2027 (%)
TABLE 7 GLOBAL FUNCTIONAL FOOD & BEVERAGES VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 8 GLOBAL FUNCTIONAL FOOD & BEVERAGES VITAMIN D MARKET 2021–2027 (%)
TABLE 9 GLOBAL PERSONAL CARE VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 10 GLOBAL PERSONAL CARE VITAMIN D MARKET 2021–2027 (%)
TABLE 11 GLOBAL DRY VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 12 GLOBAL DRY VITAMIN D MARKET 2021–2027 (%)
TABLE 13 GLOBAL LIQUID VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 14 GLOBAL LIQUID VITAMIN D MARKET 2021–2027 (%)
TABLE 15 GLOBAL VITAMIN D MARKET BY VITAMIN D3 2021−2027 ($ MILLION)
TABLE 16 GLOBAL VITAMIN D MARKET BY VITAMIN D3 2021−2027 (%)
TABLE 17 GLOBAL VITAMIN D MARKET BY VITAMIN D2 2021−2027 ($ MILLION)
TABLE 18 GLOBAL VITAMIN D MARKET BY 2021−2027 (%)
TABLE 19 GLOBAL HUMAN VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 20 GLOBAL HUMAN VITAMIN D MARKET BY HUMANS 2021–2027 (%)
TABLE 21 GLOBAL ANIMAL VITAMIN D MARKET 2021–2027 ($ MILLION)
TABLE 22 GLOBAL ANIMAL VITAMIN D MARKET 2021–2027 (%)
TABLE 23 EUROPE VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 24 EUROPE VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 25 EUROPE VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 26 EUROPE VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 27 EUROPE VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 28 EUROPE VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 29 EUROPE VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 30 EUROPE VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 31 NORTH AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 32 NORTH AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 33 NORTH AMERICA VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 34 NORTH AMERICA VITAMIN D MARKET BY FORM 2021−2027 (%)
TABLE 35 NORTH AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 36 NORTH AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 37 NORTH AMERICA VITAMIN D MARKET BY END-USER 2021−2027 ($ MILLION)
TABLE 38 NORTH AMERICA VITAMIN D MARKET BY END-USER 2021−2027 (%)
TABLE 39 APAC VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 40 APAC VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 41 APAC VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 42 APAC VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 43 APAC VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 44 APAC VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 45 APAC VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 46 APAC VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 47 SOME POPULAR VITAMIN D PRODUCTS AVAILABLE IN INDIAN MARKET
TABLE 48 MILK FORTIFICATION LANDSCAPE WITH VITAMIN D IN INDIA
TABLE 49 LATIN AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 50 LATIN AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 51 LATIN AMERICA VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 52 LATIN AMERICA VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 53 LATIN AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 54 LATIN AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 55 LATIN AMERICA VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 56 LATIN AMERICA VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 57 MIDDLE EAST & AFRICA VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 58 MIDDLE EAST & AFRICA VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 59 MIDDLE EAST & AFRICA VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 60 MIDDLE EAST & AFRICA VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 61 MIDDLE EAST & AFRICA VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 62 MIDDLE EAST & AFRICA VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 63 MIDDLE EAST & AFRICA VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 64 MIDDLE EAST & AFRICA VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 65 BASF: MAJOR PRODUCT OFFERINGS
TABLE 66 FERMENTA BIOTECH: MAJOR PRODUCT OFFERINGS
TABLE 67 DSM: MAJOR PRODUCT OFFERINGS
TABLE 68 DISHMAN CARBOGEN AMCIS: MAJOR PRODUCT OFFERINGS
TABLE 69 ZHEJIANG GARDEN BIOCHEMICAL HIGH-TECH: MAJOR PRODUCT OFFERINGS
TABLE 70 ADISSEO: MAJOR PRODUCT OFFERINGS
TABLE 71 SYNTHESIA: MAJOR PRODUCT OFFERINGS
TABLE 72 VITABLEND: MAJOR PRODUCT OFFERINGS
TABLE 73 NEWGEN PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 74 SICHUAN NEIJIANG HUIXIN PHARMACY: MAJOR PRODUCT OFFERINGS
TABLE 75 HANGZHOU THINK CHEMICAL: MAJOR PRODUCT OFFERINGS
TABLE 76 LYCORED: MAJOR PRODUCT OFFERINGS
TABLE 77 PHARMAVIT: MAJOR PRODUCT OFFERINGS
TABLE 78 DIVI’S NUTRACEUTICALS: MAJOR PRODUCT OFFERINGS
TABLE 79 TOCRIS BIOSCIENCE: MAJOR PRODUCT OFFERINGS
TABLE 80 SPECTRUM CHEMICAL: MAJOR PRODUCT OFFERINGS
TABLE 81 STABICOAT VITAMINS: MAJOR PRODUCT OFFERINGS
TABLE 82 XIAMEN KINGDOMWAY GROUP: MAJOR PRODUCT OFFERINGS
TABLE 83 ZHEJIANG NHU: MAJOR PRODUCT OFFERINGS
TABLE 84 GLOBAL VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 85 GLOBAL VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 86 EUROPE VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 87 EUROPE VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 88 NORTH AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 89 NORTH AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 90 APAC VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 91 APAC VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 92 LATIN AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 93 LATIN AMERICA VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 94 MIDDLE EAST & AFRICA VITAMIN D MARKET BY APPLICATION 2021–2027 ($ MILLION)
TABLE 95 MIDDLE EAST & AFRICA VITAMIN D MARKET BY APPLICATION 2021–2027 (%)
TABLE 96 GLOBAL VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 97 GLOBAL VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 98 EUROPE VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 99 EUROPE VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 100 NORTH AMERICA VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 101 NORTH AMERICA VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 102 APAC VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 103 APAC VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 104 LATIN AMERICA VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 105 LATIN AMERICA VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 106 MIDDLE EAST & AFRICA VITAMIN D MARKET BY FORM 2021–2027 ($ MILLION)
TABLE 107 MIDDLE EAST & AFRICA VITAMIN D MARKET BY FORM 2021–2027 (%)
TABLE 108 VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 109 VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 110 EUROPE VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 111 EUROPE VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 112 NORTH AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 113 NORTH AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 114 APAC VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 115 APAC VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 116 LATIN AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 117 LATIN AMERICA VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 118 MIDDLE EAST & AFRICA VITAMIN D MARKET BY ANALOG 2021–2027 ($ MILLION)
TABLE 119 MIDDLE EAST & AFRICA VITAMIN D MARKET BY ANALOG 2021–2027 (%)
TABLE 120 VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 121 VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 122 EUROPE VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 123 EUROPE VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 124 NORTH AMERICA VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 125 NORTH AMERICA VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 126 APAC VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 127 APAC VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 128 LATIN AMERICA VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 129 LATIN AMERICA VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 130 MIDDLE EAST & AFRICA VITAMIN D MARKET BY END-USER 2021–2027 ($ MILLION)
TABLE 131 MIDDLE EAST & AFRICA VITAMIN D MARKET BY END-USER 2021–2027 (%)
TABLE 132 GLOBAL VITAMIN D MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)
TABLE 133 GLOBAL VITAMIN D MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 134 GLOBAL VITAMIN D MARKET BY PHARMACEUTICALS 2021–2027 ($ MILLION)
TABLE 135 GLOBAL VITAMIN D MARKET BY PHARMACEUTICALS 2021–2027 (%)
TABLE 136 GLOBAL VITAMIN D MARKET BY ANIMAL HEALTH 2021–2027 ($ MILLION)
TABLE 137 GLOBAL VITAMIN D MARKET BY ANIMAL HEALTH 2021–2027 (%)
TABLE 138 GLOBAL VITAMIN D MARKET BY FUNCTIONAL FOOD & BEVERAGES 2021–2027 ($ MILLION)
TABLE 139 GLOBAL VITAMIN D MARKET BY FUNCTIONAL FOOD & BEVERAGES 2021–2027 (%)
TABLE 140 GLOBAL VITAMIN D MARKET BY PERSONAL CARE 2021–2027 ($ MILLION)
TABLE 141 GLOBAL VITAMIN D MARKET BY PERSONAL CARE 2021–2027 (%)
TABLE 142 GLOBAL VITAMIN D MARKET BY VITAMIN D3 2021–2027 ($ MILLION)
TABLE 143 GLOBAL VITAMIN D MARKET BY VITAMIN D3 2021–2027 (%)
TABLE 144 GLOBAL VITAMIN D MARKET BY VITAMIN D2 2021–2027 ($ MILLION)
TABLE 145 GLOBAL VITAMIN D MARKET BY VITAMIN D2 2021–2027 (%)
TABLE 146 GLOBAL VITAMIN D MARKET BY DRY FORM 2021–2027 ($ MILLION)
TABLE 147 GLOBAL VITAMIN D MARKET BY DRY FORM 2021–2027 (%)
TABLE 148 GLOBAL VITAMIN D MARKET BY LIQUID FORM 2021–2027 ($ MILLION)
TABLE 149 GLOBAL VITAMIN D MARKET BY LIQUID FORM 2021–2027 (%)
TABLE 150 GLOBAL VITAMIN D MARKET BY HUMANS 2021–2027 ($ MILLION)
TABLE 151 GLOBAL VITAMIN D MARKET BY HUMANS 2021–2027 (%)
TABLE 152 GLOBAL VITAMIN D MARKET BY ANIMALS 2021–2027 ($ MILLION)
TABLE 153 GLOBAL VITAMIN D MARKET BY ANIMALS 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
